ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

168
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
Refresh
bullish3SBio Inc
27 Jan 2016 10:48

China's FDA Ups Its Game

One of the pharmaceutical industry’s main complaints about China is the extremely slow drug approval process. The approval process in China...

Share
16 Dec 2015 16:22

HEC ChangJiang Pharma IPO - Just a Manufacturing Shell

YiChang HEC ChangJiang Pharmaceuticals (YHCP) plans to raise US$160-215m through an issuance of primary shares in its IPO.We've worked along...

Logo
370 Views
Share
06 Feb 2015 15:02

Can Innovation labs be assessed to pick stocks for your portfolio?

Companies across different industries are building Innovation centers  in Singapore, Hong Kong and other cities across Asia and the rest of the...

Logo
672 Views
Share
05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
309 Views
Share
22 Jan 2015 07:01

Hutchison Whampoa Restructuring: Next Move for Watson's?

The announced restructuring of Cheung Kong Limited and Hutchison Whampoa Limited has been well received on the HKEx. Hutchison shares have rallied...

Share
x